Real-world registry-based study on apremilast use in psoriasis and psoriatic arthritis in Finland (Jan, 10.1080/03009742.2022.2151109, 2023)

I Koskivirta,J. Ruotsalainen,S. Kurki,P. Lakkakorpi,H. Salminen-Mankonen,L. Pirila,R. Harvima,A. Palomaki

Scandinavian journal of rheumatology（2023）

引用 2|浏览1

暂无评分

摘要

In Finnish clinical practice, apremilast is mainly used between conventional synthetic therapy and biologics, with at least as high treatment persistence as reported in previous studies. Apremilast users were older with higher comorbidity burden than biologics users.

查看译文

关键词

apremilast use,psoriatic arthritis,psoriasis,real-world,registry-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要